Volume 35 Number 10 September 3-10, 2015
Cancer
American Society of Clinical Oncology policy statement update: Genetic and genomic testing for cancer susceptibility
Robson ME, et al. JCO.2015.63.0996
Robson ME, et al. JCO.2015.63.0996
Genetic cancer susceptibility testing: Increased technology, increased complexity
Yu PP, et al. JCO.2015.63.3628
Yu PP, et al. JCO.2015.63.3628
Association between use of the 21-gene recurrence score assay and receipt of chemotherapy among Medicare beneficiaries with early-stage breast cancer, 2005-2009.
Dinan MA et al. JAMA Oncol 2015 Aug 27.
Dinan MA et al. JAMA Oncol 2015 Aug 27.
Counselees' expressed level of understanding of the risk estimate and surveillance recommendation are not associated with breast cancer surveillance adherence.
Albada A et al. J Genet Couns 2015 Sep 1.
Albada A et al. J Genet Couns 2015 Sep 1.
EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital Trust.
Berg J et al. Acta Oncol 2015 Aug 27. 1-7
Berg J et al. Acta Oncol 2015 Aug 27. 1-7
Improving patient outcomes with cancer genomics
Schnepp RW, et al. JAMA. 2015;314(9):881-883.
Schnepp RW, et al. JAMA. 2015;314(9):881-883.
Integrative clinical sequencing in the management of refractory or relapsed cancer in youth
Moody RJ, et al. JAMA. 2015;314(9):913-925.
Moody RJ, et al. JAMA. 2015;314(9):913-925.
MSIplus: Integrated colorectal cancer molecular testing by next-generation sequencing.
Hempelmann JA et al. J Mol Diagn 2015 Aug 28.
Hempelmann JA et al. J Mol Diagn 2015 Aug 28.
Molecular testing in anatomic pathology and adherence to guidelines: A College of American Pathologists Q-probes study of 2230 testing events reported by 26 institutions.
Volmar KE et al. Arch. Pathol. Lab. Med. 2015 Sep 139(9) 1115-24
Volmar KE et al. Arch. Pathol. Lab. Med. 2015 Sep 139(9) 1115-24
Obesity, aspirin, and risk of colorectal cancer in carriers of hereditary colorectal cancer: A prospective investigation in the CAPP2 study.
Movahedi M et al. J. Clin. Oncol. 2015 Aug 17.
Movahedi M et al. J. Clin. Oncol. 2015 Aug 17.
Patients tested at a laboratory for hereditary cancer syndromes show an overlap for multiple syndromes in their personal and familial cancer histories.
Saam J et al. Oncology 2015 Aug 28.
Saam J et al. Oncology 2015 Aug 28.
Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study.
Siebenhofer A et al. BMC Cancer 2015 15(1) 605
Siebenhofer A et al. BMC Cancer 2015 15(1) 605
Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.
Hyman DM et al. Drug Discov. Today 2015 Aug 27.
Hyman DM et al. Drug Discov. Today 2015 Aug 27.
Precision medicine in breast cancer care: An early glimpse of impact.
Kurian AW et al. JAMA Oncol 2015 Aug 27.
Kurian AW et al. JAMA Oncol 2015 Aug 27.
Service delivery model and experiences in a cancer genetics clinic for an underserved population.
Woodson AH et al. J Health Care Poor Underserved 2015 26(3) 784-91
Woodson AH et al. J Health Care Poor Underserved 2015 26(3) 784-91
The development of rapid and accurate screening test for RET hotspot somatic and germline mutations in MEN2 syndromes.
Zupan A et al. Exp. Mol. Pathol. 2015 Aug 27.
Zupan A et al. Exp. Mol. Pathol. 2015 Aug 27.
The influence of screening for precancerous lesions on family-based genetic association tests: An example of colorectal polyps and cancer.
Schmit SL et al. Am. J. Epidemiol. 2015 Aug 24.
Schmit SL et al. Am. J. Epidemiol. 2015 Aug 24.
No hay comentarios:
Publicar un comentario